Switching from one CD20-targeting therapy to another doesn't alter their ability to lower disease activity and slow disability progression.

Columnist Ben Hofmeister says he makes sure to ask questions in a healthcare setting because his experience as a patient is important.

A study found neurofilament light chain at high levels in the blood and CSF of MS patients, suggesting its potential as a ...

Susan Payrovi, MD, and Mirla Avila, MD, discuss early gut microbiome formation and its lifelong influence on MS and immune ...

Columnist Desiree Lama describes her unexpected joy at having a new cat join her existing feline friend, especially when they ...

Women in their childbearing years are significantly less likely than men in the same age range to be given disease-modifying ...

Medications that promote repair of the myelin sheath that protects nerve cells may help limit damage due to MS, a trial ...

Natalie Caez shares how MS has changed her life, from mobility struggles to learning patience, grace, and finding the right support system.

Lindsay Kelly shares her journey as a caregiver for her husband with progressive MS, highlighting self-care and resilience.

Marisa Wexler is a senior science writer for Multiple Sclerosis News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of multiple ...

Patricia Inacio is a science writer for Multiple Sclerosis News Today with a PhD in cell biology. She covers the latest news and information on a variety of multiple sclerosis topics.

Three prevalent symptoms in MS – fatigue, mobility and cognitive impairment – generally aren't barriers to healthy habits, a ...